32 related articles for article (PubMed ID: 32152615)
1. Primary nonadherence to statin medications in a managed care organization.
Cheetham TC; Niu F; Green K; Scott RD; Derose SF; Vansomphone SS; Shin J; Tunceli K; Reynolds K
J Manag Care Pharm; 2013 Jun; 19(5):367-73. PubMed ID: 23697474
[TBL] [Abstract][Full Text] [Related]
2. Lack of Awareness of Own Hypercholesterolemia or Statin Medication among Adult Statin Users in the United States: Prevalence and Patient Characteristics in a Repeated Cross-Sectional Study.
Imai K; Sugiyama T; Ohsugi M; Kakei M; Hara K
Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627634
[TBL] [Abstract][Full Text] [Related]
3. Regularity and Continuity of GP Contacts and Use of Statins Amongst People at Risk of Cardiovascular Events.
Youens D; Doust J; Robinson S; Moorin R
J Gen Intern Med; 2021 Jun; 36(6):1656-1665. PubMed ID: 33655384
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation and switching of therapy after initiation of lipid-lowering drugs: the effects of comorbidities and patient characteristics.
Yang CC; Jick SS; Testa MA
Br J Clin Pharmacol; 2003 Jul; 56(1):84-91. PubMed ID: 12848779
[TBL] [Abstract][Full Text] [Related]
5. Effect of Statin Therapy on Age-Associated Changes in Physical Function Among Men With and Without HIV in the Multicenter AIDS Cohort Study.
Abdo M; Langan SJ; MaWhinney S; Sun J; Lake JE; Palella FJ; Kingsley L; Brown TT; Erlandson KM
J Acquir Immune Defic Syndr; 2021 Apr; 86(4):455-462. PubMed ID: 33230030
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacokinetic evaluation of nanoparticle-based vs. conventional pharmaceuticals containing statins in attenuating dyslipidaemia.
Cordina J; Ahmad I; Nath R; Abdul Rahim B; Van A; Al-Zuhairi D; Williams K; Pont L; Catanzariti R; Mehndiratta S; Valdivia-Olivares RY; De Rubis G; Dua K
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; ():. PubMed ID: 38717707
[TBL] [Abstract][Full Text] [Related]
7. [Statin use in patients with liver disease - overview and results from a retrospektive observational study].
Markova A; Wedemeyer H
MMW Fortschr Med; 2021 Feb; 163(3):74-77. PubMed ID: 33591527
[No Abstract] [Full Text] [Related]
8. Fracture risk in women with osteoporosis initiated on gastro-resistant risedronate versus immediate release risedronate or alendronate: a claims data analysis in the USA.
Eisman JA; Cortet B; Boolell M; Ionescu-Ittu R; Vekeman F; Heroux J; Thomasius F
Osteoporos Int; 2023 May; 34(5):977-991. PubMed ID: 36872338
[TBL] [Abstract][Full Text] [Related]
9. Determinants of Non-Adherence to the Medications for Dyslipidemia: A Systematic Review.
Lopes J; Santos P
Patient Prefer Adherence; 2021; 15():1853-1871. PubMed ID: 34465984
[TBL] [Abstract][Full Text] [Related]
10. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study.
Watanabe JH; Kazerooni R; Bounthavong M
J Manag Care Pharm; 2014 Jan; 20(1):43-50. PubMed ID: 24372459
[TBL] [Abstract][Full Text] [Related]
11. A systematic review and economic evaluation of statins for the prevention of coronary events.
Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
[TBL] [Abstract][Full Text] [Related]
12. Did Australia's COVID-19 Restrictions Impact Statin Incidence, Prevalence or Adherence?
Livori AC; Lukose D; Bell JS; Webb GI; Ilomäki J
Curr Probl Cardiol; 2023 Apr; 48(4):101576. PubMed ID: 36586705
[TBL] [Abstract][Full Text] [Related]
13. Predictors of ceasing or reducing statin medication following a large increase in the consumer copayment for medications: a retrospective observational study.
Seamon K; Sanfilippo F; Bulsara M; Roughead L; Kemp-Casey A; Bulsara C; Watts GF; Preen D
Public Health Res Pract; 2020 Mar; 30(1):. PubMed ID: 32152615
[TBL] [Abstract][Full Text] [Related]
14. Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase.
Seaman KL; Sanfilippo FM; Bulsara MK; Brett T; Kemp-Casey A; Roughead EE; Bulsara C; Preen DB
Aust Health Rev; 2020 Jun; 44(3):377-384. PubMed ID: 32389176
[TBL] [Abstract][Full Text] [Related]
15. Impact of consumer copayments for subsidised medicines on health services use and outcomes: a protocol using linked administrative data from Western Australia.
Seaman KL; Sanfilippo FM; Roughead EE; Bulsara MK; Kemp-Casey A; Bulsara C; Watts GF; Preen D
BMJ Open; 2017 Jun; 7(6):e013691. PubMed ID: 28637723
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
